• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用突变事件的定性观察进行贝叶斯推理对基因突变进行离散时间演化建模。

DEGBOE: Discrete time Evolution modeling of Gene mutation through Bayesian inference using qualitative Observation of mutation Events.

机构信息

Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC 27709, United States.

出版信息

J Biomed Inform. 2022 Oct;134:104197. doi: 10.1016/j.jbi.2022.104197. Epub 2022 Sep 6.

DOI:10.1016/j.jbi.2022.104197
PMID:36084801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9809132/
Abstract

An important aspect of cancer progression concerns the way in which gene mutations accumulate in cellular lineages. Comprehensive efforts into cataloging cancer genes have revealed that tumors demonstrate variability in genes that accumulate mutations which depend on the presence or absence of other mutations. However, understanding the stochastic process by which mutations arise across the genome is an important open problem of this nature in biology due to modeling discrete variate time-series is the most challenging, and, as yet, least well-developed of all areas of research in time-series. In this paper, a DEGBOE framework is proposed to model the mutation time-series given the sequence data of the gene mutations. The method relates the discrete-time, nonlinear and nonstationary series of gene mutations to the time-varying autoregressive moving average model. It presents the observation as a nonlinear function dependent on two variables: gene mutation, and gene-gene interactions characterizing the effects of the varying presence or absence of other gene mutations on a mutations' occurrence and evolution. DEGBOE is applied to model the dynamics of frequently mutated genes in lung cancer, includingEGFR,KRAS, and TP53. The results of the model are analyzed and compared to the original simulated data of theDNAwalk, and experimental lung cancer mutations data. It identifies the driver role of TP53 mutations in lung cancer progression.

摘要

癌症进展的一个重要方面涉及基因突变在细胞谱系中积累的方式。全面的癌症基因编目工作表明,肿瘤在积累突变的基因方面存在变异性,这取决于其他突变的存在与否。然而,由于对离散变量时间序列进行建模是生物学中此类性质的一个重要的开放性问题,因此了解基因组中突变的随机过程仍然是一个挑战,而且在时间序列的所有研究领域中,它仍然是发展最不完善的领域。在本文中,提出了一个 DEGBOE 框架来对基因突变的序列数据进行基因突变时间序列建模。该方法将基因突变的离散时间、非线性和非平稳序列与时变自回归移动平均模型联系起来。它将观察结果表示为一个依赖于两个变量的非线性函数:基因突变和基因-基因相互作用,它们描述了其他基因突变的不同存在或缺失对突变发生和进化的影响。DEGBOE 被应用于模拟肺癌中经常发生突变的基因的动力学,包括 EGFR、KRAS 和 TP53。对模型的结果进行了分析,并与 DNAwalk 的原始模拟数据和实验性肺癌突变数据进行了比较。它确定了 TP53 突变在肺癌进展中的驱动作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/ddb4bf8747c9/nihms-1837212-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/8f9848d9f2a1/nihms-1837212-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/cbe64813219d/nihms-1837212-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/5b7bdae06c5c/nihms-1837212-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/7945c730845e/nihms-1837212-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/72673a0fa935/nihms-1837212-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/2b5547adb6cf/nihms-1837212-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/ddb4bf8747c9/nihms-1837212-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/8f9848d9f2a1/nihms-1837212-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/cbe64813219d/nihms-1837212-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/5b7bdae06c5c/nihms-1837212-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/7945c730845e/nihms-1837212-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/72673a0fa935/nihms-1837212-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/2b5547adb6cf/nihms-1837212-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e373/9809132/ddb4bf8747c9/nihms-1837212-f0008.jpg

相似文献

1
DEGBOE: Discrete time Evolution modeling of Gene mutation through Bayesian inference using qualitative Observation of mutation Events.通过使用突变事件的定性观察进行贝叶斯推理对基因突变进行离散时间演化建模。
J Biomed Inform. 2022 Oct;134:104197. doi: 10.1016/j.jbi.2022.104197. Epub 2022 Sep 6.
2
Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma.STK11和TP53与肺腺癌中KRAS突变相关基因表达、增殖及免疫监视的差异关联
Oncogene. 2016 Jun 16;35(24):3209-16. doi: 10.1038/onc.2015.375. Epub 2015 Oct 19.
3
KRAS and TP53 mutations in bronchoscopy samples from former lung cancer patients.来自既往肺癌患者支气管镜检查样本中的KRAS和TP53突变
Mol Carcinog. 2017 Feb;56(2):381-388. doi: 10.1002/mc.22501. Epub 2016 Jun 6.
4
Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.肺癌中 KRAS、DDR2 和 TP53 基因突变的分布:伊朗患者的分析。
PLoS One. 2018 Jul 26;13(7):e0200633. doi: 10.1371/journal.pone.0200633. eCollection 2018.
5
Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.TP53 基因突变类型影响肺特异性转基因小鼠中的致癌潜能和相关 K-ras 突变谱。
Int J Cancer. 2019 Nov 1;145(9):2418-2426. doi: 10.1002/ijc.32279. Epub 2019 Apr 13.
6
Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.EGFR和KRAS突变型肺腺癌中TP53的突变及p14(arf)表达的改变。
Clin Lung Cancer. 2014 Mar;15(2):124-30. doi: 10.1016/j.cllc.2013.08.003. Epub 2013 Oct 26.
7
YTHDF1 Promotes Cyclin B1 Translation through mA Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.YTHDF1 通过 mA 调控促进细胞周期蛋白 B1 的翻译,促进 KRAS/TP53 共突变肺腺癌的不良预后。
Cells. 2021 Jul 2;10(7):1669. doi: 10.3390/cells10071669.
8
Potential Predictive Value of and Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma.在肺腺癌中, 与 突变状态对 PD-1 阻断免疫治疗反应的潜在预测价值。
Clin Cancer Res. 2017 Jun 15;23(12):3012-3024. doi: 10.1158/1078-0432.CCR-16-2554. Epub 2016 Dec 30.
9
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.非小细胞肺癌中的 K-ras 基因突变亚型及其他致癌通路中的相关共发生突变。
J Thorac Oncol. 2019 Apr;14(4):606-616. doi: 10.1016/j.jtho.2018.12.013. Epub 2018 Dec 31.
10
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.基于人群的非小细胞肺癌队列中的突变模式以及 KRAS 和 TP53 或 STK11 同时突变的预后影响。
Lung Cancer. 2019 Apr;130:50-58. doi: 10.1016/j.lungcan.2019.01.003. Epub 2019 Jan 9.

引用本文的文献

1
Boosting data interpretation with GIBOOST to enhance visualization of complex high-dimensional data.使用GIBOOST增强数据解释,以提升复杂高维数据的可视化效果。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf415.

本文引用的文献

1
TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.TP53 突变通过 Sp1/Sp3 上调 RCP 的表达,从而驱动肺癌的进展。
Oncogene. 2022 Apr;41(16):2357-2371. doi: 10.1038/s41388-022-02260-7. Epub 2022 Mar 7.
2
Comprehensive Review of Models and Methods for Inferences in Bio-Chemical Reaction Networks.生化反应网络推理模型与方法综述
Front Genet. 2019 Jun 14;10:549. doi: 10.3389/fgene.2019.00549. eCollection 2019.
3
In silico learning of tumor evolution through mutational time series.通过突变时间序列进行肿瘤进化的计算学习。
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9501-9510. doi: 10.1073/pnas.1901695116. Epub 2019 Apr 23.
4
A Stochastic Phylogenetic Algorithm for Mitochondrial DNA Analysis.一种用于线粒体DNA分析的随机系统发育算法。
Front Genet. 2019 Mar 8;10:66. doi: 10.3389/fgene.2019.00066. eCollection 2019.
5
Sequence based prediction of enhancer regions from DNA random walk.基于 DNA 随机游走的增强子区域的序列预测。
Sci Rep. 2018 Oct 29;8(1):15912. doi: 10.1038/s41598-018-33413-y.
6
Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.结核肉芽肿中异烟肼和利福平耐药的出现与选择。
PLoS One. 2018 May 10;13(5):e0196322. doi: 10.1371/journal.pone.0196322. eCollection 2018.
7
Modeling Cell-to-Cell Communication Networks Using Response-Time Distributions.使用反应时间分布对细胞间通讯网络进行建模。
Cell Syst. 2018 Mar 28;6(3):355-367.e5. doi: 10.1016/j.cels.2018.01.016. Epub 2018 Mar 7.
8
Consistency of detrended fluctuation analysis.去趋势波动分析的一致性。
Phys Rev E. 2017 Jul;96(1-1):012141. doi: 10.1103/PhysRevE.96.012141. Epub 2017 Jul 21.
9
Engineering Natural Killer Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化自然杀伤细胞
Mol Ther. 2017 Aug 2;25(8):1769-1781. doi: 10.1016/j.ymthe.2017.06.012. Epub 2017 Jun 28.
10
Tissue-specific tumorigenesis: context matters.组织特异性肿瘤发生:背景很重要。
Nat Rev Cancer. 2017 Apr;17(4):239-253. doi: 10.1038/nrc.2017.5. Epub 2017 Mar 3.